Profile of brentuximab vedotin and its potential in the treatment of relapsed or refractory Hodgkin lymphoma

Mayes S, Gibb A, Illidge T

Blood and Lymphatic Cancer: Targets and Therapy 2012, 2:99-107

Published Date: 21 May 2012